Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay

Journal of Analytical Toxicology

Volumn 24, Issue 1, 2000, Pages 46-53

  Rasanen, Ilpo ^a   Ojanperä, Ilkka ^a   Vuori, Erkki ^a  

^a Department of Forensic Medicine ^*  (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; DEMOXEPAM; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; MIDAZOLAM; NITRAZEPAM; NORCLOBAZAM; OXAZEPAM; PHENAZEPAM; PRAZEPAM; TEMAZEPAM;

ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STRUCTURE; ELECTRON CAPTURE DETECTION; GAS CHROMATOGRAPHY; IMMUNOASSAY; QUANTITATIVE DIAGNOSIS;

EID: 0033956840     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/24.1.46     Document Type: Article

References (32)

1. H. Maurer and K. Pfleger. Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry. J. Chromatogr. 422: 85-101 (1987).
2. S.J. Mule and G.A. Gasella. Quantitation and confirmation of the diazolo- and triazolobenzodiazepines in human urine by gas chromatography/mass spectrometry. J. Anal. Toxicol. 13: 179-184 (1989).
3. P.H. Dickson, W. Markus, J. McKernan, and H.C. Nipper. Urinalysis of α-hydroxyalprazolam, α-hydroxytriazolam and other benzodiazepine compounds by GC/EIMS. J. Anal. Toxicol. 16: 67-71 (1992).
4. W.A. Joern. Confirmation of low concentrations of urinary benzodiazepines, including alprazolam and triazolam by GC/MS: an extractive alkylation procedure. J. Anal. Toxicol. 16: 363-367 (1992).
5. R.E. West and D.P. Ritz. GC/MS analysis of five common benzodiazepine metabolites in urine as tert-butyl-dimethylsilyl derivatives. J. Anal. Toxicol. 17: 114-116 (1993).
6. R.L. Fitzgerald, D.A. Rexin, and D.A. Herold. Benzodiazepine analysis by negative chemical ionization gas chromatography/mass spectrometry. J. Anal. Toxicol. 17: 342-347 (1993).
7. D.A. Black, G.D. Clark, V.M. Haver, J.A. Garbin, and A.J. Saxon. Analysis of urinary benzodiazepines using solid-phase extraction and gas chromatography-mass spectrometry. J. Anal. Toxicol. 18: 185-188 (1994).
8. L.E. Edinboro and A. Poklis. Detection of benzodiazepines and tribenzazolams by TRIAGE™: confirmation by solid-phase extraction utilizing SPEC®·3ML·MP3 microcolumns and GC-MS. J. Anal. Toxicol. 18: 312-316 (1994).
9. R. Meatherall. GC-MS confirmation of urinary benzodiazepine metabolites. J. Anal. Toxicol. 18: 369-381 (1994).
10. R.L. Fitzgerald, D.A. Rexin, and D.A. Herold. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin. Chem. 40: 373-380 (1994).
11. C. Moore, G. Long, and M. Marr. Confirmation of benzodiazepines in urine as trimethylsilyl derivatives using gas chromatography/mass spectrometry. J. Chromatogr. B 655: 132-137 (1994).
12. S.B. Needleman and M. Porvaznik. Identification of parent benzodiazepines by gas chromatography/mass spectroscopy (GC/MS) from urinary extracts treated with β-glucuronidase. Forensic Sci. Int. 73: 49-60 (1995).
13. J.W. King and L.J. King. Solid-phase extraction and on-disc derivatization of the major benzodiazepines in urine using enzyme hydrolysis and Toxi-Lab VC MP3 column. J. Anal. Toxicol. 20: 262-265 (1996).
14. J.L. Valentine, R. Middleton, and C. Sparks. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens. J. Anal. Toxicol. 20: 416-424 (1996).
15. O. Beck, Z. Lin, K. Brodin, S. Borg, and P. Hjemdahl. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS. J. Anal. Toxicol. 21: 554-557 (1997).
16. H.W. Peel and B.J. Perrigo. Toxicological analysis of benzodiazepine-type compounds in post-mortem blood by gas chromatography. J. Anal. Toxicol. 4: 105-113 (1980).
17. J.M.F. Douse. Trace analysis of benzodiazepine drugs in blood using deactivated amberlite XAD-7 porous polymer beads and silica capillary column gas chromatography with electron-capture detection. J. Chromatogr. 301: 137-154 (1984).
18. P. Lillsunde and T. Seppälä. Simultaneous screening and quantitative analysis of benzodiazepines by dual-column gas chromatography using electron-capture and nitrogen-phosphorus detection. J. Chromatogr. Biomed. Appl. 553: 97-110 (1990).
19. H. Gjerde, E. Dahlin, and A.S. Christophersen. Simultaneous determination of common benzodiazepines in blood using capillary gas chromatography. J. Pharm. Biomed. Anal. 10: 317-322 (1992).
20. Y. Gaillard, J.-P. Gay-Montchamp, and M. Ollagnier. Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction. J. Chromatogr. Biomed. Appl. 622: 197-208 (1993).
21. P. Mura, A. Piriou, P. Fraillon, Y. Papet, and D. Reiss. Screening procedure for benzodiazepines in biological fluids by high-performance liquid chromatography using a rapid-scanning multichannel detector. J. Chromatogr. Biomed. Appl. 416: 303-310 (1987).
22. F. Mußhoff and T. Daldrup. A rapid solid-phase extraction and HPLC/DAD procedure for the simultaneous determination and quantification of different benzodiazepines in serum, blood and post-mortem blood. Int. J. Leg. Med. 105: 105-109 (1992).
23. I.A. McIntyre, M.L. Syrjanen, K. Crump, S. Horomidis, A.W. Peace, and O.F. Drummer. Simultaneous HPLC analysis of 15 benzodiazepines and selected metabolites in postmortem blood. J. Anal. Toxicol. 17: 202-207 (1993).
24. W. He, N. Parissis, and T. Kiratzidis. Determination of benzodiazepines in forensic samples by HPLC with photo-diode array detection. J. Forensic Sci. 43: 1061-1067 (1998).
25. I. Rasanen, I. Ojanperä, E. Vuori, and T.A. Hase. An homologous series of benzodiazepine retention index standards for gas chromatography. J. High Res. Chromatogr. 16: 495-500 (1993).
26. I. Rasanen, I. Ojanperä, J. Vartiovaara, E. Vuori, and P. Sunila. The advantage of dual-column approach and retention indices combined with refined reporting in gas chromatographic drug screening. J. High. Res. Chromatogr. 19: 313-321 (1996).
27. L. Huber. Validation of analytical methods: review and strategy. LC-GC Int. 11(2): 96-105 (1998).
28. M.D. Robertson and O.H. Drummer. High-performance liquid chromatographic procedure for the measurement of nitrobenzodiazepines and their 7-amino metabolites in blood. J. Chromatogr. Biomed. Appl. 667: 179-184 (1995).
29. W.A. Joern and A.B. Joern. Detection of alprazolam (Xanax) and its metabolites in urine using dual column, dual nitrogen detector gas chromatography. J. Anal. Toxicol. 11: 247-251 (1987).
30. O. Beck, P. Lafolie, G. Odelius, and L.O. Boreus. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol. Lett. 52: 7-14 (1990).
31. P. Simonsson, A. Lidén, and S. Lindberg. Effect of β-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarization immunoassay. Clin. Chem. 41: 920-923 (1995).
32. R. Meatherall. Benzodiazepine screening using EMIT® II and TDx®: urine hydrolysis pretreatment required. J. Anal. Toxicol. 18: 385-390 (1994).